Scott Milsten - Dec 30, 2022 Form 4/A - Amendment Insider Report for e.l.f. Beauty, Inc. (ELF)

Role
Other*
Signature
/s/ Scott K. Milsten
Stock symbol
ELF
Transactions as of
Dec 30, 2022
Transactions value $
-$266,238
Form type
4/A - Amendment
Date filed
1/11/2023, 03:12 PM
Date Of Original Report
Jan 3, 2023
Previous filing
Aug 8, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELF Common Stock, $0.01 par value Options Exercise $9.2K +5K +3.92% $1.84* 133K Dec 30, 2022 Direct F1, F2
transaction ELF Common Stock, $0.01 par value Sale -$275K -5K -3.77% $55.09 128K Dec 30, 2022 Direct F1, F2, F3
holding ELF Common Stock, $0.01 par value 22.8K Dec 30, 2022 By Milsten/Conner Trust dated October 17, 2008

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELF Stock Option (Right to Buy) Options Exercise $0 -5K -3.44% $0.00 140K Dec 30, 2022 Common Stock 5K $1.84 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 Includes 62,190 Restricted Stock Units.
F3 The transaction was executed in multiple trades in prices ranging from $54.64 to $55.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Fully vested.

Remarks:

Senior Vice President, General Counsel, Corporate Secretary & Chief People Officer Amendment filed to correct number in Table II, Column 9